What is it about?
In this study, it was aimed to investigate the impact of Thymoquinone (TQ) on cancer cells with and without KRAS mutations to better understand why TQ exhibits varying anticancer effects in different types of cancer cells.
Featured Image
Why is it important?
Our findings revealed that KRAS mutations appear to diminish the effectiveness of TQ in reducing cell viability and inducing apoptosis.
Read the Original
This page is a summary of: KRAS Mutation Reduces Thymoquinone Anticancer Effects on Viability of Cells and
Apoptosis, Anti-Cancer Agents in Medicinal Chemistry, September 2023, Bentham Science Publishers,
DOI: 10.2174/1871520623666230517123807.
You can read the full text:
Contributors
The following have contributed to this page
